Medicine & Life Sciences
Systematic Reviews
100%
Cost-Benefit Analysis
72%
axicabtagene ciloleucel
33%
Randomized Controlled Trials
31%
Gallstones
28%
Cholinergic Antagonists
28%
Testosterone
26%
Cholecystitis
21%
Quality-Adjusted Life Years
21%
Costs and Cost Analysis
20%
Delivery of Health Care
20%
Vitamin K
20%
Status Epilepticus
19%
relugolix
19%
Meta-Analysis
19%
Cholecystectomy
18%
National Institutes of Health (U.S.)
17%
ivosidenib
17%
Psoriasis
17%
Therapeutics
16%
fostamatinib
16%
MEDLINE
16%
teduglutide
16%
Conservative Treatment
15%
Chronic Renal Insufficiency
15%
Data Analysis
14%
Dialysis
14%
Databases
14%
Eunuchism
14%
Microbial Collagenase
14%
secukinumab
13%
venetoclax
13%
Hypogonadism
13%
Confidence Intervals
13%
Peanut Hypersensitivity
13%
Norethindrone Acetate
13%
Point-of-Care Systems
13%
Lorazepam
12%
Dupuytren Contracture
12%
Midazolam
12%
Caregivers
12%
Observation
12%
Short Bowel Syndrome
11%
Dexmedetomidine
11%
Biomedical Technology Assessment
10%
Equipment and Supplies
10%
Emergency Treatment
10%
Mortality
10%
Idiopathic Thrombocytopenic Purpura
10%
Inguinal Hernia
10%
Social Sciences
costs
28%
aggregate data
22%
evaluation
20%
economics
20%
chronic illness
18%
mortality
16%
surgery
15%
life years
14%
confidence
13%
management
13%
evidence
12%
event
10%
nutrition situation
10%
seizure
9%
trend
7%
pain
7%
adverse events
7%
health
7%
monitoring
7%
drug
7%
Healthcare
6%
technology assessment
6%
allergy
5%
electronics
5%